Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2023-2029

Page: 125

Published Date: 17 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Intravenous Immunoglobulin(IVIg) Therapy production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin(IVIg) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin(IVIg) Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Intravenous Immunoglobulin(IVIg) Therapy total production and demand, 2018-2029, (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy total production value, 2018-2029, (USD Million)
Global Intravenous Immunoglobulin(IVIg) Therapy production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Intravenous Immunoglobulin(IVIg) Therapy domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin(IVIg) Therapy production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Intravenous Immunoglobulin(IVIg) Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TEIJIN LIMITED, Grifols, Biotest, Kamada, Takeda, Octapharma, Kedrion, LFB Group and Baxter, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin(IVIg) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Intravenous Immunoglobulin(IVIg) Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Intravenous Immunoglobulin(IVIg) Therapy Market, Segmentation by Type
    1g/20ml
    1.25g/25ml
    2.5g/50ml
    5g/100ml
    10g/200ml
    Others

Global Intravenous Immunoglobulin(IVIg) Therapy Market, Segmentation by Application
    Immunodeficiency
    Autoimmune Disease
    Acute Infection
    Others

Companies Profiled:
    TEIJIN LIMITED
    Grifols
    Biotest
    Kamada
    Takeda
    Octapharma
    Kedrion
    LFB Group
    Baxter
    Nanyue Biopharming
    Boya-Bio
    CSL Plasma
    CNBG
    Beijing Tiantan Biological Products
    Hualan Bio
    Guangdong Shuagnlin Bio-pharmacy
    Weiguang Biological
    Sinopharm
    Shanghai RAAS
    Taibang Biologic Group

Key Questions Answered
1. How big is the global Intravenous Immunoglobulin(IVIg) Therapy market?
2. What is the demand of the global Intravenous Immunoglobulin(IVIg) Therapy market?
3. What is the year over year growth of the global Intravenous Immunoglobulin(IVIg) Therapy market?
4. What is the production and production value of the global Intravenous Immunoglobulin(IVIg) Therapy market?
5. Who are the key producers in the global Intravenous Immunoglobulin(IVIg) Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Intravenous Immunoglobulin(IVIg) Therapy Introduction
    1.2 World Intravenous Immunoglobulin(IVIg) Therapy Supply & Forecast
        1.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value (2018 & 2022 & 2029)
        1.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029)
        1.2.3 World Intravenous Immunoglobulin(IVIg) Therapy Pricing Trends (2018-2029)
    1.3 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (Based on Production Site)
        1.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2018-2029)
        1.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2018-2029)
        1.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2018-2029)
        1.3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029)
        1.3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029)
        1.3.6 China Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029)
        1.3.7 Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Intravenous Immunoglobulin(IVIg) Therapy Demand (2018-2029)
    2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region
        2.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2018-2023)
        2.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2024-2029)
    2.3 United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.4 China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.6 Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.7 South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.8 ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)
    2.9 India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029)

3 World Intravenous Immunoglobulin(IVIg) Therapy Manufacturers Competitive Analysis
    3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2018-2023)
    3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2018-2023)
    3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2018-2023)
    3.4 Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy in 2022
        3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy in 2022
    3.6 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
        3.6.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
        3.6.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
        3.6.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison
        4.1.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison
        4.2.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison
        4.3.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023)
    4.5 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share
        4.5.1 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2018-2023)
        4.5.3 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023)
    4.6 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023)

5 Market Analysis by Type
    5.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 1g/20ml
        5.2.2 1.25g/25ml
        5.2.3 2.5g/50ml
        5.2.4 5g/100ml
        5.2.5 10g/200ml
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2018-2029)
        5.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2018-2029)
        5.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Immunodeficiency
        6.2.2 Autoimmune Disease
        6.2.3 Acute Infection
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2018-2029)
        6.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2018-2029)
        6.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2018-2029)

7 Company Profiles
    7.1 TEIJIN LIMITED
        7.1.1 TEIJIN LIMITED Details
        7.1.2 TEIJIN LIMITED Major Business
        7.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 TEIJIN LIMITED Recent Developments/Updates
        7.1.6 TEIJIN LIMITED Competitive Strengths & Weaknesses
    7.2 Grifols
        7.2.1 Grifols Details
        7.2.2 Grifols Major Business
        7.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Grifols Recent Developments/Updates
        7.2.6 Grifols Competitive Strengths & Weaknesses
    7.3 Biotest
        7.3.1 Biotest Details
        7.3.2 Biotest Major Business
        7.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biotest Recent Developments/Updates
        7.3.6 Biotest Competitive Strengths & Weaknesses
    7.4 Kamada
        7.4.1 Kamada Details
        7.4.2 Kamada Major Business
        7.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kamada Recent Developments/Updates
        7.4.6 Kamada Competitive Strengths & Weaknesses
    7.5 Takeda
        7.5.1 Takeda Details
        7.5.2 Takeda Major Business
        7.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Takeda Recent Developments/Updates
        7.5.6 Takeda Competitive Strengths & Weaknesses
    7.6 Octapharma
        7.6.1 Octapharma Details
        7.6.2 Octapharma Major Business
        7.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Octapharma Recent Developments/Updates
        7.6.6 Octapharma Competitive Strengths & Weaknesses
    7.7 Kedrion
        7.7.1 Kedrion Details
        7.7.2 Kedrion Major Business
        7.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.7.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Kedrion Recent Developments/Updates
        7.7.6 Kedrion Competitive Strengths & Weaknesses
    7.8 LFB Group
        7.8.1 LFB Group Details
        7.8.2 LFB Group Major Business
        7.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 LFB Group Recent Developments/Updates
        7.8.6 LFB Group Competitive Strengths & Weaknesses
    7.9 Baxter
        7.9.1 Baxter Details
        7.9.2 Baxter Major Business
        7.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Baxter Recent Developments/Updates
        7.9.6 Baxter Competitive Strengths & Weaknesses
    7.10 Nanyue Biopharming
        7.10.1 Nanyue Biopharming Details
        7.10.2 Nanyue Biopharming Major Business
        7.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Nanyue Biopharming Recent Developments/Updates
        7.10.6 Nanyue Biopharming Competitive Strengths & Weaknesses
    7.11 Boya-Bio
        7.11.1 Boya-Bio Details
        7.11.2 Boya-Bio Major Business
        7.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Boya-Bio Recent Developments/Updates
        7.11.6 Boya-Bio Competitive Strengths & Weaknesses
    7.12 CSL Plasma
        7.12.1 CSL Plasma Details
        7.12.2 CSL Plasma Major Business
        7.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 CSL Plasma Recent Developments/Updates
        7.12.6 CSL Plasma Competitive Strengths & Weaknesses
    7.13 CNBG
        7.13.1 CNBG Details
        7.13.2 CNBG Major Business
        7.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 CNBG Recent Developments/Updates
        7.13.6 CNBG Competitive Strengths & Weaknesses
    7.14 Beijing Tiantan Biological Products
        7.14.1 Beijing Tiantan Biological Products Details
        7.14.2 Beijing Tiantan Biological Products Major Business
        7.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
        7.14.6 Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
    7.15 Hualan Bio
        7.15.1 Hualan Bio Details
        7.15.2 Hualan Bio Major Business
        7.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Hualan Bio Recent Developments/Updates
        7.15.6 Hualan Bio Competitive Strengths & Weaknesses
    7.16 Guangdong Shuagnlin Bio-pharmacy
        7.16.1 Guangdong Shuagnlin Bio-pharmacy Details
        7.16.2 Guangdong Shuagnlin Bio-pharmacy Major Business
        7.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
        7.16.6 Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
    7.17 Weiguang Biological
        7.17.1 Weiguang Biological Details
        7.17.2 Weiguang Biological Major Business
        7.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Weiguang Biological Recent Developments/Updates
        7.17.6 Weiguang Biological Competitive Strengths & Weaknesses
    7.18 Sinopharm
        7.18.1 Sinopharm Details
        7.18.2 Sinopharm Major Business
        7.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Sinopharm Recent Developments/Updates
        7.18.6 Sinopharm Competitive Strengths & Weaknesses
    7.19 Shanghai RAAS
        7.19.1 Shanghai RAAS Details
        7.19.2 Shanghai RAAS Major Business
        7.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Shanghai RAAS Recent Developments/Updates
        7.19.6 Shanghai RAAS Competitive Strengths & Weaknesses
    7.20 Taibang Biologic Group
        7.20.1 Taibang Biologic Group Details
        7.20.2 Taibang Biologic Group Major Business
        7.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
        7.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Taibang Biologic Group Recent Developments/Updates
        7.20.6 Taibang Biologic Group Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
    8.2 Intravenous Immunoglobulin(IVIg) Therapy Upstream Analysis
        8.2.1 Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
        8.2.2 Main Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Intravenous Immunoglobulin(IVIg) Therapy Production Mode
    8.6 Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
    8.7 Intravenous Immunoglobulin(IVIg) Therapy Industry Sales Model and Sales Channels
        8.7.1 Intravenous Immunoglobulin(IVIg) Therapy Sales Model
        8.7.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2018-2023)
    Table 5. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2024-2029)
    Table 6. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2018-2023) & (K Units)
    Table 7. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2024-2029) & (K Units)
    Table 8. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2018-2023)
    Table 9. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2024-2029)
    Table 10. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
    Table 13. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2018-2023) & (K Units)
    Table 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2022
    Table 18. World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2022
    Table 20. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
    Table 22. World Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
    Table 24. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
    Table 25. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
    Table 26. Intravenous Immunoglobulin(IVIg) Therapy Competitive Factors
    Table 27. Intravenous Immunoglobulin(IVIg) Therapy New Entrant and Capacity Expansion Plans
    Table 28. Intravenous Immunoglobulin(IVIg) Therapy Mergers & Acquisitions Activity
    Table 29. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2018-2023)
    Table 37. China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2018-2023)
    Table 42. Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2018-2023)
    Table 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2018-2023) & (K Units)
    Table 49. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2024-2029) & (K Units)
    Table 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2018-2023) & (K Units)
    Table 56. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2024-2029) & (K Units)
    Table 57. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. TEIJIN LIMITED Basic Information, Manufacturing Base and Competitors
    Table 62. TEIJIN LIMITED Major Business
    Table 63. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 64. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. TEIJIN LIMITED Recent Developments/Updates
    Table 66. TEIJIN LIMITED Competitive Strengths & Weaknesses
    Table 67. Grifols Basic Information, Manufacturing Base and Competitors
    Table 68. Grifols Major Business
    Table 69. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 70. Grifols Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Grifols Recent Developments/Updates
    Table 72. Grifols Competitive Strengths & Weaknesses
    Table 73. Biotest Basic Information, Manufacturing Base and Competitors
    Table 74. Biotest Major Business
    Table 75. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 76. Biotest Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biotest Recent Developments/Updates
    Table 78. Biotest Competitive Strengths & Weaknesses
    Table 79. Kamada Basic Information, Manufacturing Base and Competitors
    Table 80. Kamada Major Business
    Table 81. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 82. Kamada Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kamada Recent Developments/Updates
    Table 84. Kamada Competitive Strengths & Weaknesses
    Table 85. Takeda Basic Information, Manufacturing Base and Competitors
    Table 86. Takeda Major Business
    Table 87. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 88. Takeda Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Takeda Recent Developments/Updates
    Table 90. Takeda Competitive Strengths & Weaknesses
    Table 91. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 92. Octapharma Major Business
    Table 93. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 94. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Octapharma Recent Developments/Updates
    Table 96. Octapharma Competitive Strengths & Weaknesses
    Table 97. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 98. Kedrion Major Business
    Table 99. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 100. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Kedrion Recent Developments/Updates
    Table 102. Kedrion Competitive Strengths & Weaknesses
    Table 103. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 104. LFB Group Major Business
    Table 105. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 106. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. LFB Group Recent Developments/Updates
    Table 108. LFB Group Competitive Strengths & Weaknesses
    Table 109. Baxter Basic Information, Manufacturing Base and Competitors
    Table 110. Baxter Major Business
    Table 111. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 112. Baxter Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Baxter Recent Developments/Updates
    Table 114. Baxter Competitive Strengths & Weaknesses
    Table 115. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
    Table 116. Nanyue Biopharming Major Business
    Table 117. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 118. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Nanyue Biopharming Recent Developments/Updates
    Table 120. Nanyue Biopharming Competitive Strengths & Weaknesses
    Table 121. Boya-Bio Basic Information, Manufacturing Base and Competitors
    Table 122. Boya-Bio Major Business
    Table 123. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 124. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Boya-Bio Recent Developments/Updates
    Table 126. Boya-Bio Competitive Strengths & Weaknesses
    Table 127. CSL Plasma Basic Information, Manufacturing Base and Competitors
    Table 128. CSL Plasma Major Business
    Table 129. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 130. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. CSL Plasma Recent Developments/Updates
    Table 132. CSL Plasma Competitive Strengths & Weaknesses
    Table 133. CNBG Basic Information, Manufacturing Base and Competitors
    Table 134. CNBG Major Business
    Table 135. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 136. CNBG Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. CNBG Recent Developments/Updates
    Table 138. CNBG Competitive Strengths & Weaknesses
    Table 139. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
    Table 140. Beijing Tiantan Biological Products Major Business
    Table 141. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 142. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Beijing Tiantan Biological Products Recent Developments/Updates
    Table 144. Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
    Table 145. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 146. Hualan Bio Major Business
    Table 147. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 148. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Hualan Bio Recent Developments/Updates
    Table 150. Hualan Bio Competitive Strengths & Weaknesses
    Table 151. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
    Table 152. Guangdong Shuagnlin Bio-pharmacy Major Business
    Table 153. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 154. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
    Table 156. Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
    Table 157. Weiguang Biological Basic Information, Manufacturing Base and Competitors
    Table 158. Weiguang Biological Major Business
    Table 159. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 160. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Weiguang Biological Recent Developments/Updates
    Table 162. Weiguang Biological Competitive Strengths & Weaknesses
    Table 163. Sinopharm Basic Information, Manufacturing Base and Competitors
    Table 164. Sinopharm Major Business
    Table 165. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 166. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Sinopharm Recent Developments/Updates
    Table 168. Sinopharm Competitive Strengths & Weaknesses
    Table 169. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 170. Shanghai RAAS Major Business
    Table 171. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 172. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Shanghai RAAS Recent Developments/Updates
    Table 174. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
    Table 175. Taibang Biologic Group Major Business
    Table 176. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
    Table 177. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 178. Global Key Players of Intravenous Immunoglobulin(IVIg) Therapy Upstream (Raw Materials)
    Table 179. Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
    Table 180. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
List of Figure
    Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
    Figure 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029) & (K Units)
    Figure 5. World Intravenous Immunoglobulin(IVIg) Therapy Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2018-2029)
    Figure 7. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2018-2029)
    Figure 8. North America Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029) & (K Units)
    Figure 9. Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029) & (K Units)
    Figure 10. China Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029) & (K Units)
    Figure 11. Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2018-2029) & (K Units)
    Figure 12. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share by Region (2018-2029)
    Figure 16. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 17. China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 18. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 19. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 22. India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2022
    Figure 26. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2022
    Figure 30. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2022
    Figure 32. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type in 2022
    Figure 34. 1g/20ml
    Figure 35. 1.25g/25ml
    Figure 36. 2.5g/50ml
    Figure 37. 5g/100ml
    Figure 38. 10g/200ml
    Figure 39. Others
    Figure 40. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Type (2018-2029)
    Figure 41. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type (2018-2029)
    Figure 42. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2018-2029) & (US$/Unit)
    Figure 43. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 44. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application in 2022
    Figure 45. Immunodeficiency
    Figure 46. Autoimmune Disease
    Figure 47. Acute Infection
    Figure 48. Others
    Figure 49. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Application (2018-2029)
    Figure 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application (2018-2029)
    Figure 51. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2018-2029) & (US$/Unit)
    Figure 52. Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
    Figure 53. Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
    Figure 54. Intravenous Immunoglobulin(IVIg) Therapy Sales Model
    Figure 55. Intravenous Immunoglobulin(IVIg) Therapy Sales Channels, Direct Sales, and Distribution
    Figure 56. Methodology
    Figure 57. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Intravenous Immunoglobulin(IVIg) Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intravenous Immunoglobulin(IVIg) Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Intravenous Immunoglobulin(IVIg) Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2024-2030

Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2024-2030

date 01 Mar 2024

date Pharma & Healthcare

The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Intravenous Immunoglobulin(IVIg) Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>